These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8648206)

  • 1. IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response.
    Rodriguez-Barradas MC; Groover JE; Lacke CE; Gump DW; Lahart CJ; Pandey JP; Musher DM
    J Infect Dis; 1996 Jun; 173(6):1347-53. PubMed ID: 8648206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of antibody response to tetanus toxoid and pneumococcal capsular polysaccharides in patients infected with HIV.
    Talesnik E; Vial PA; Labarca J; Méndez C; Soza X
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):471-7. PubMed ID: 9859960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine.
    Rodriguez-Barradas MC; Musher DM; Lahart C; Lacke C; Groover J; Watson D; Baughn R; Cate T; Crofoot G
    J Infect Dis; 1992 Mar; 165(3):553-6. PubMed ID: 1347058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic regulation of the capacity to make immunoglobulin G to pneumococcal capsular polysaccharides.
    Musher DM; Groover JE; Watson DA; Pandey JP; Rodriguez-Barradas MC; Baughn RE; Pollack MS; Graviss EA; de Andrade M; Amos CI
    J Investig Med; 1997 Feb; 45(2):57-68. PubMed ID: 9084576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative change in antibody responses of human immunodeficiency virus-infected individuals to pneumococcal capsular polysaccharide vaccination associated with highly active antiretroviral therapy.
    Subramaniam KS; Segal R; Lyles RH; Rodriguez-Barradas MC; Pirofski LA
    J Infect Dis; 2003 Mar; 187(5):758-68. PubMed ID: 12599049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of recent human immunodeficiency virus seroconverters to the pneumococcal polysaccharide vaccine and Haemophilus influenzae type b conjugate vaccine.
    Weiss PJ; Wallace MR; Oldfield EC; O'Brien J; Janoff EN
    J Infect Dis; 1995 May; 171(5):1217-22. PubMed ID: 7751696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial.
    Ahmed F; Steinhoff MC; Rodriguez-Barradas MC; Hamilton RG; Musher DM; Nelson KE
    J Infect Dis; 1996 Jan; 173(1):83-90. PubMed ID: 8537687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lack of association between aging and postvaccination levels of IgG antibody to capsular polysaccharides of Streptococcus pneumoniae.
    Musher DM; Groover JE; Graviss EA; Baughn RE
    Clin Infect Dis; 1996 Jan; 22(1):165-7. PubMed ID: 8824989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adults.
    Feikin DR; Elie CM; Goetz MB; Lennox JL; Carlone GM; Romero-Steiner S; Holder PF; O'Brien WA; Whitney CG; Butler JC; Breiman RF
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):137-41. PubMed ID: 14715560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody class and subclass responses to pneumococcal polysaccharides following immunization of human immunodeficiency virus-infected patients.
    Carson PJ; Schut RL; Simpson ML; O'Brien J; Janoff EN
    J Infect Dis; 1995 Aug; 172(2):340-5. PubMed ID: 7622875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults.
    Crum-Cianflone NF; Huppler Hullsiek K; Roediger M; Ganesan A; Patel S; Landrum ML; Weintrob A; Agan BK; Medina S; Rahkola J; Hale BR; Janoff EN;
    J Infect Dis; 2010 Oct; 202(7):1114-25. PubMed ID: 20795819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis.
    Bjornson AB; Falletta JM; Verter JI; Buchanan GR; Miller ST; Pegelow CH; Iyer RV; Johnstone HS; DeBaun MR; Wethers DL; Wang WC; Woods GM; Holbrook CT; Becton DL; Kinney TR; Reaman GH; Kalinyak K; Grossman NJ; Vichinsky E; Reid CD
    J Pediatr; 1996 Dec; 129(6):828-35. PubMed ID: 8969724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults.
    Musher DM; Manof SB; Liss C; McFetridge RD; Marchese RD; Bushnell B; Alvarez F; Painter C; Blum MD; Silber JL
    J Infect Dis; 2010 Feb; 201(4):516-24. PubMed ID: 20092407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children.
    Thanee C; Pancharoen C; Likitnukul S; Luangwedchakarn V; Umrod P; Phasomsap C; Apornpong T; Chuanchareon T; Butterworth O; Puthanakit T
    Vaccine; 2011 Aug; 29(35):5886-91. PubMed ID: 21729732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly.
    Sankilampi U; Honkanen PO; Bloigu A; Herva E; Leinonen M
    J Infect Dis; 1996 Feb; 173(2):387-93. PubMed ID: 8568300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative and Qualitative Antibody Responses to Immunization With the Pneumococcal Polysaccharide Vaccine in HIV-Infected Patients After Initiation of Antiretroviral Treatment: Results From a Randomized Clinical Trial.
    Rodriguez-Barradas MC; Serpa JA; Munjal I; Mendoza D; Rueda AM; Mushtaq M; Pirofski LA
    J Infect Dis; 2015 Jun; 211(11):1703-11. PubMed ID: 25538270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to pneumococcal capsular polysaccharides in children with human immunodeficiency virus infection given polyvalent pneumococcal vaccine.
    Arpadi SM; Back S; O'Brien J; Janoff EN
    J Pediatr; 1994 Jul; 125(1):77-9. PubMed ID: 8021792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of human immunodeficiency virus infection on the IgA and IgG antibody responses to pneumococcal vaccine.
    Mascart-Lemone F; Gérard M; Libin M; Crusiaux A; Franchioly P; Lambrechts A; Goldman M; Clumeck N
    J Infect Dis; 1995 Nov; 172(5):1253-60. PubMed ID: 7594661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination.
    Bhorat AE; Madhi SA; Laudat F; Sundaraiyer V; Gurtman A; Jansen KU; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B
    AIDS; 2015 Jul; 29(11):1345-54. PubMed ID: 25888646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections.
    Hidalgo H; Moore C; Leiva LE; Sorensen RU
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):341-6. PubMed ID: 8612116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.